BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 33280618)

  • 1. Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation.
    Bacciardi S; Elefante C; Brancati GE; Mazzucchi S; Del Prete E; Frosini D; Maremmani I; Lattanzi L; Ceravolo R; Bonuccelli U; Perugi G
    CNS Spectr; 2022 Jun; 27(3):355-361. PubMed ID: 33280618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity.
    Pettorruso M; Fasano A; De Risio L; Ricciardi L; Di Nicola M; Martinotti G; Janiri L; Bentivoglio AR
    J Neurol Sci; 2016 Mar; 362():344-7. PubMed ID: 26944176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical spectrum of impulse control disorders in Parkinson's disease.
    Weintraub D; David AS; Evans AH; Grant JE; Stacy M
    Mov Disord; 2015 Feb; 30(2):121-7. PubMed ID: 25370355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomania and mania related to dopamine replacement therapy in Parkinson's disease.
    Maier F; Merkl J; Ellereit AL; Lewis CJ; Eggers C; Pedrosa DJ; Kalbe E; Kuhn J; Meyer TD; Zurowski M; Timmermann L
    Parkinsonism Relat Disord; 2014 Apr; 20(4):421-7. PubMed ID: 24467817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulse control and related disorders in Parkinson's disease.
    Weintraub D; Nirenberg MJ
    Neurodegener Dis; 2013; 11(2):63-71. PubMed ID: 23038208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulse control and related behaviors in Parkinson's disease with dementia.
    Martinez-Martin P; Wan YM; Ray Chaudhuri K; Schrag AE; Weintraub D
    Eur J Neurol; 2020 Jun; 27(6):944-950. PubMed ID: 32048392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort.
    Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P;
    Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
    Catalan MJ; Molina-Arjona JA; Mir P; Cubo E; Arbelo JM; Martinez-Martin P;
    J Neurol; 2018 Jun; 265(6):1279-1287. PubMed ID: 29557989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroencephalogram-Driven Machine-Learning Scenario for Assessing Impulse Control Disorder Comorbidity in Parkinson's Disease Using a Low-Cost, Custom LEGO-Like Headset.
    Lin WC; Chen WJ; Chen YS; Liang HY; Lu CH; Lin YP
    IEEE Trans Neural Syst Rehabil Eng; 2023; 31():4106-4114. PubMed ID: 37819826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study.
    Kon T; Ueno T; Haga R; Tomiyama M
    Brain Behav; 2018 Aug; 8(8):e01036. PubMed ID: 29956879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.
    Hinkle JT; Perepezko K; Rosenthal LS; Mills KA; Pantelyat A; Mari Z; Tochen L; Bang JY; Gudavalli M; Yoritomo N; Butala A; Bakker CC; Johnson V; Moukheiber E; Dawson TM; Pontone GM
    Parkinsonism Relat Disord; 2018 Feb; 47():50-56. PubMed ID: 29198499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
    Biundo R; Weis L; Abbruzzese G; Calandra-Buonaura G; Cortelli P; Jori MC; Lopiano L; Marconi R; Matinella A; Morgante F; Nicoletti A; Tamburini T; Tinazzi M; Zappia M; Vorovenci RJ; Antonini A
    Mov Disord; 2017 Nov; 32(11):1557-1565. PubMed ID: 28960475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.
    Cormier-Dequaire F; Bekadar S; Anheim M; Lebbah S; Pelissolo A; Krack P; Lacomblez L; Lhommée E; Castrioto A; Azulay JP; Defebvre L; Kreisler A; Durif F; Marques-Raquel A; Brefel-Courbon C; Grabli D; Roze E; Llorca PM; Ory-Magne F; Benatru I; Ansquer S; Maltête D; Tir M; Krystkowiak P; Tranchant C; Lagha-Boukbiza O; Lebrun-Vignes B; Mangone G; Vidailhet M; Charbonnier-Beaupel F; Rascol O; Lesage S; Brice A; Tezenas du Montcel S; Corvol JC;
    Mov Disord; 2018 Dec; 33(12):1878-1886. PubMed ID: 30444952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulse control disorders in Parkinson's disease: crossroads between neurology, psychiatry and neuroscience.
    Bugalho P; Oliveira-Maia AJ
    Behav Neurol; 2013 Jan; 27(4):547-57. PubMed ID: 23242359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine and impulse control disorders in Parkinson's disease.
    Weintraub D
    Ann Neurol; 2008 Dec; 64 Suppl 2(Suppl 2):S93-100. PubMed ID: 19127573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compulsive behaviors in patients with Parkinson's disease.
    Kenangil G; Ozekmekçi S; Sohtaoglu M; Erginöz E
    Neurologist; 2010 May; 16(3):192-5. PubMed ID: 20445429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and clinical characteristics of hypersexuality in patients with Parkinson's disease following dopaminergic therapy: A systematic literature review.
    Nakum S; Cavanna AE
    Parkinsonism Relat Disord; 2016 Apr; 25():10-6. PubMed ID: 26923525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.
    Ramirez-Zamora A; Gee L; Boyd J; Biller J
    Expert Rev Neurother; 2016; 16(4):389-99. PubMed ID: 26923084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.